Catalyst
Slingshot members are tracking this event:
Phase III KATHERINE data presented of Kadcyla vs Herceptin in HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RHHBY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 15, 2018
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Kadcyla, Herceptin
